BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 41 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,387,403 | -1.4% | 2,211,000 | 0.0% | 0.00% | -20.0% |
Q1 2023 | $1,406,749 | +55.7% | 2,211,000 | 0.0% | 0.01% | +66.7% |
Q4 2022 | $903,746 | -6.6% | 2,211,000 | 0.0% | 0.00% | -25.0% |
Q3 2022 | $968,000 | -3.7% | 2,211,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,005,000 | +6.1% | 2,211,000 | +10.6% | 0.00% | +33.3% |
Q1 2022 | $947,000 | – | 2,000,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Diameter Capital Partners LP | 71,757,000 | $44,221,686 | 4.15% |
Context Capital Management, LLC | 33,683 | $20,846 | 1.88% |
INHERENT GROUP, LP | 9,000,000 | $5,587,173 | 1.54% |
BRAIDWELL LP | 62,294,000 | $38,552,328 | 1.26% |
Aequim Alternative Investments LP | 30,000,000 | $18,566,312 | 0.70% |
DeepCurrents Investment Group LLC | 22,355,000 | $13,838,372 | 0.55% |
ABSOLUTE INVESTMENT ADVISERS, LLC | 5,500,000 | $3,408,592 | 0.48% |
ARISTEIA CAPITAL, L.L.C. | 30,280,000 | $18,739,598 | 0.42% |
Weiss Asset Management LP | 4,500,000 | $2,773,209 | 0.21% |
Orbimed Advisors | 15,000,000 | $9,265,350 | 0.17% |